Related Experiment Video
Updated: Jul 13, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems
Brian G Trewyn1, Supratim Giri, Igor I Slowing
1Department of Chemistry and U.S. DOE Ames Laboratory, Iowa State University, Ames, Iowa 50011, USA.
Chemical Communications (Cambridge, England)
|August 2, 2007
Summary
Functional mesoporous silica materials offer enhanced biocompatibility for drug and gene delivery systems. These advanced nanomaterials also show promise as highly selective sensors for detecting biological molecules.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Recent progress in controlling surface properties and morphology of mesoporous silica materials has significantly improved their biocompatibility.
- These materials possess high surface area (>700 m²/g) and pore volume (>1 cm³/g), with tunable pore diameters (2-30 nm) and narrow size distributions.
Purpose of the Study:
- To review recent research on functional mesoporous silica materials for stimuli-responsive controlled release.
- To summarize breakthroughs in using these nanomaterials as sensors for selective detection of biological molecules.
Main Methods:
- Functionalization of internal pore and exterior particle surfaces of mesoporous silicates.
- Design of materials for stimuli-responsive release of drugs, genes, and chemicals.
- Development of nanoscale porous materials for selective sensing applications.
Main Results:
- Enhanced biocompatibility of structurally defined mesoporous silica.
- Successful functionalization strategies for tunable pore characteristics.
- Demonstrated potential in controlled release systems and selective biosensing.
Conclusions:
- Functional mesoporous silica materials are highly promising for advanced drug/gene delivery and chemical sensing.
- Continued research in designing these nanomaterials will drive innovation in biomedical and chemical applications.
Related Concept Videos
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...